Clinical and analytical considerations in the study of health status in device trials for heart failure.

[1]  Jennifer L. Embree,et al.  Discriminant properties of commonly used quality of life measures in heart failure , 2004, Quality of Life Research.

[2]  L. Tavazzi,et al.  Antiremodeling Effect of Long-Term Exercise Training in Patients With Stable Chronic Heart Failure: Results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial , 2003, Circulation.

[3]  A. Baxter,et al.  β Blockers in older persons with heart failure: tolerability and impact on quality of life , 2002 .

[4]  J. Schafer,et al.  Missing data: our view of the state of the art. , 2002, Psychological methods.

[5]  J. Spertus,et al.  Examining the concordance between patient and physician assessments of health status in heart failure patients , 2002 .

[6]  J. Douglas,et al.  Item response models for joint analysis of quality of life and survival , 2002, Statistics in medicine.

[7]  N. Santanello,et al.  Regulatory issues for health-related quality of life--PhRMA Health Outcomes Committee workshop, 1999. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  G. Molenberghs,et al.  Linear Mixed Models for Longitudinal Data , 2001 .

[9]  M D Schluchter,et al.  Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease , 2001, Statistics in medicine.

[10]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[11]  J. Lachin.  Worst-rank score analysis with informatively missing observations in clinical trials. , 1999, Controlled clinical trials.

[12]  B. Bozkurt,et al.  Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. , 1999, Circulation.

[13]  S J Pocock,et al.  Estimation and comparison of rates of change in longitudinal studies with informative drop-outs. , 1999, Statistics in medicine.

[14]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[15]  A. Wu,et al.  Health status versus quality of life in older patients: does the distinction matter? , 1999, The American journal of medicine.

[16]  D. DeMets,et al.  A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure , 1998 .

[17]  J Hilden,et al.  Quality adjusted survival analysis with repeated quality of life measures. , 1998, Statistics in medicine.

[18]  Ron D. Hays,et al.  Quality of life assessment in clinical trials : methods and practice , 1998 .

[19]  A. Leplège,et al.  The problem of quality of life in medicine. , 1997, JAMA.

[20]  S. Gottlieb,et al.  Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. , 1996, Circulation.

[21]  D. Rubin.  Multiple Imputation After 18+ Years , 1996 .

[22]  D. Simonson,et al.  Assessment of quality-of-life outcomes. , 1996, The New England journal of medicine.

[23]  R. Little,et al.  Pattern-mixture models for multivariate incomplete data with covariates. , 1996, Biometrics.

[24]  T. Rector,et al.  Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. , 1995, Journal of cardiac failure.

[25]  I. Wilson,et al.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. , 1995, JAMA.

[26]  T M Gill,et al.  A critical appraisal of the quality of quality-of-life measurements. , 1994, JAMA.

[27]  B. Massie,et al.  Can Further Benefit Be Achieved by Adding Flosequinan to Patients With Congestive Heart Failure Who Remain Symptomatic on Diuretic, Digoxin, and an Angiotensin Converting Enzyme Inhibitor? Results of the Flosequinan‐ACE Inhibitor Trial (FACET) , 1993, Circulation.

[28]  J. Cohn,et al.  Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. , 1993, Circulation.

[29]  J. Cohn,et al.  Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.

[30]  R. Niaura,et al.  Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. , 1993, The American journal of cardiology.

[31]  Gordon Guyatt,et al.  Measuring Health-Related Quality of Life , 1993, Annals of Internal Medicine.

[32]  R. Little.  Pattern-Mixture Models for Multivariate Incomplete Data , 1993 .

[33]  G H Guyatt,et al.  Measuring health status: what are the necessary measurement properties? , 1992, Journal of clinical epidemiology.

[34]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[35]  J. Weiss,et al.  Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.

[36]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[37]  Duane F. Alwin,et al.  Problems in the estimation and interpretation of the reliability of survey data , 1989 .

[38]  G. Guyatt,et al.  Measuring quality of life in clinical trials: a taxonomy and review. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[39]  G H Guyatt,et al.  Responsiveness and validity in health status measurement: a clarification. , 1989, Journal of clinical epidemiology.

[40]  G. Guyatt,et al.  Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.

[41]  P. O'Brien.  Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.